United Kingdom Diabetes Market Size, Share, Trends and Forecast by Segment and Distribution Channel, 2026-2034
The United Kingdom diabetes market size was valued at USD 1.72 Billion in 2025 and is projected to reach USD 2.30 Billion by 2034, exhibiting a CAGR of 3.14% during the forecast period 2026-2034. Rising type-2 diabetes prevalence, the ageing UK population, growing adoption of GLP-1 therapies such as semaglutide and tirzepatide, NHS drug reimbursement expansion under NICE’s 2024 guideline updates, and steady uptake of biosimilar insulin analogues are driving the UK diabetes market growth. Insulin leads the product segment at 53.3% in 2025, while Oral Antidiabetics hold 46.7%. Retail Pharmacies dominate distribution at 53.6% in 2025, supported by the UK’s strong community pharmacy network.
This new report “United Kingdom Diabetes Market Report: 2026-2034” provides an analytical and statistical insight into the UK diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in UK. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the UK diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the UK diabetes market in any form.
What this Report Achieves:
Comprehensive situation analysis of the UK diabetes epidemiology and its dynamics:
Focus of the Analysis:
Historical, current and future prevalence of diabetes in UK
Historical, current and future prevalence of type-1 and type-2 diabetes in UK
Historical, current and future prevalence of diabetes in the urban and rural regions in UK
Historical, current and future prevalence of diabetes among males and females in UK
Historical, current and future prevalence of diabetes among various age groups in UK
Historical, current and future diagnosis rates for diabetes in UK
Historical, current and future drug treatment rates for diabetes in UK
Comprehensive situation analysis of the UK Oral Antidiabetics market and its dynamics:
Focus of the Analysis:
Performance of the Oral Antidiabetics market in UK
Performance of key classes
Performance of key players
Market outlook
Comprehensive situation analysis of the UK Insulin market and its dynamics:
Focus of the Analysis:
Performance of the Insulin market in UK
Performance of key classes
Performance of key players
Market outlook
KEY QUESTIONS ANSWERED IN THIS REPORT
1.What is the UK diabetes market size in 2025?
2.What is the UK diabetes market forecast through 2034?
3.Which segment leads the UK diabetes market?
4.Which distribution channel dominates the UK diabetes market?
5.What is driving UK diabetes market growth?
6.What is the fastest-growing channel in the UK diabetes market?
7.Who are the top companies in the UK diabetes market?
8.How are biosimilars affecting the UK diabetes market?
9.What role do GLP-1 agonists play in the UK diabetes market?
10.How does NICE affect the UK diabetes market?
11.What is the role of digital pharmacy in UK diabetes care?
This new report “United Kingdom Diabetes Market Report: 2026-2034” provides an analytical and statistical insight into the UK diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in UK. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the UK diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the UK diabetes market in any form.
What this Report Achieves:
Comprehensive situation analysis of the UK diabetes epidemiology and its dynamics:
Focus of the Analysis:
Historical, current and future prevalence of diabetes in UK
Historical, current and future prevalence of type-1 and type-2 diabetes in UK
Historical, current and future prevalence of diabetes in the urban and rural regions in UK
Historical, current and future prevalence of diabetes among males and females in UK
Historical, current and future prevalence of diabetes among various age groups in UK
Historical, current and future diagnosis rates for diabetes in UK
Historical, current and future drug treatment rates for diabetes in UK
Comprehensive situation analysis of the UK Oral Antidiabetics market and its dynamics:
Focus of the Analysis:
Performance of the Oral Antidiabetics market in UK
Performance of key classes
Performance of key players
Market outlook
Comprehensive situation analysis of the UK Insulin market and its dynamics:
Focus of the Analysis:
Performance of the Insulin market in UK
Performance of key classes
Performance of key players
Market outlook
KEY QUESTIONS ANSWERED IN THIS REPORT
1.What is the UK diabetes market size in 2025?
2.What is the UK diabetes market forecast through 2034?
3.Which segment leads the UK diabetes market?
4.Which distribution channel dominates the UK diabetes market?
5.What is driving UK diabetes market growth?
6.What is the fastest-growing channel in the UK diabetes market?
7.Who are the top companies in the UK diabetes market?
8.How are biosimilars affecting the UK diabetes market?
9.What role do GLP-1 agonists play in the UK diabetes market?
10.How does NICE affect the UK diabetes market?
11.What is the role of digital pharmacy in UK diabetes care?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 DIABETES DISEASE OVERVIEW
5.1 What is Diabetes?
5.2 Diabetes Diagnosis and Treatment
5.2.1 Diagnosis
5.2.2 Treatment
5.3 Diabetes Complications
6 UK DIABETES EPIDEMIOLOGY
6.1 Diabetes Population and Prevalence Rates
6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
6.3 Population and Prevalence Rates by Region
6.4 Population and Prevalence Rates by Gender
6.5 Population and Prevalence Rates by Age Group
7 UK DIABETES MARKET
7.1 Market Overview
7.2 Market Performance
7.3 Impact of COVID-19
7.4 Market Forecast
7.5 SWOT Analysis
7.5.1 Overview
7.5.2 Strengths
7.5.3 Weaknesses
7.5.4 Opportunities
7.5.5 Threats
7.6 Value Chain Analysis
7.7 Porter’s Five Forces Analysis
7.7.1 Overview
7.7.2 Bargaining Power of Buyers
7.7.3 Bargaining Power of Suppliers
7.7.4 Degree of Competition
7.7.5 Threat of New Entrants
7.7.6 Threat of Substitutes
7.8 Market Breakup by Segment
7.8.1 US Oral Antidiabetics Market
7.8.1.1 Historical Market Trends
7.8.1.2 Market Breakup by Class
7.8.1.3 Market Shares of Key Players
7.8.1.4 Market Forecast
7.8.2 US Insulin Market
7.8.2.1 Historical Market Trends
7.8.2.2 Market Breakup by Class
7.8.2.3 Market Shares of Key Players
7.8.2.4 Market Forecast
7.9 Market Breakup by Distribution Channel
7.9.1 E-commerce and Tele-pharmacy
7.9.1.1 Historical Market Trends
7.9.1.2 Market Forecast
7.9.2 Hospital Pharmacies
7.9.2.1 Historical Market Trends
7.9.2.2 Market Forecast
7.9.3 Retail Pharmacies
7.9.3.1 Historical Market Trends
7.9.3.2 Market Forecast
8 COMPETITIVE LANDSCAPE
8.1 Competitive Structure
8.2 Key Players
8.3 Profiles of Key Players
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 DIABETES DISEASE OVERVIEW
5.1 What is Diabetes?
5.2 Diabetes Diagnosis and Treatment
5.2.1 Diagnosis
5.2.2 Treatment
5.3 Diabetes Complications
6 UK DIABETES EPIDEMIOLOGY
6.1 Diabetes Population and Prevalence Rates
6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
6.3 Population and Prevalence Rates by Region
6.4 Population and Prevalence Rates by Gender
6.5 Population and Prevalence Rates by Age Group
7 UK DIABETES MARKET
7.1 Market Overview
7.2 Market Performance
7.3 Impact of COVID-19
7.4 Market Forecast
7.5 SWOT Analysis
7.5.1 Overview
7.5.2 Strengths
7.5.3 Weaknesses
7.5.4 Opportunities
7.5.5 Threats
7.6 Value Chain Analysis
7.7 Porter’s Five Forces Analysis
7.7.1 Overview
7.7.2 Bargaining Power of Buyers
7.7.3 Bargaining Power of Suppliers
7.7.4 Degree of Competition
7.7.5 Threat of New Entrants
7.7.6 Threat of Substitutes
7.8 Market Breakup by Segment
7.8.1 US Oral Antidiabetics Market
7.8.1.1 Historical Market Trends
7.8.1.2 Market Breakup by Class
7.8.1.3 Market Shares of Key Players
7.8.1.4 Market Forecast
7.8.2 US Insulin Market
7.8.2.1 Historical Market Trends
7.8.2.2 Market Breakup by Class
7.8.2.3 Market Shares of Key Players
7.8.2.4 Market Forecast
7.9 Market Breakup by Distribution Channel
7.9.1 E-commerce and Tele-pharmacy
7.9.1.1 Historical Market Trends
7.9.1.2 Market Forecast
7.9.2 Hospital Pharmacies
7.9.2.1 Historical Market Trends
7.9.2.2 Market Forecast
7.9.3 Retail Pharmacies
7.9.3.1 Historical Market Trends
7.9.3.2 Market Forecast
8 COMPETITIVE LANDSCAPE
8.1 Competitive Structure
8.2 Key Players
8.3 Profiles of Key Players
LIST OF FIGURES
Figure 1: The Impact of Diabetes in the Human Body
Figure 2: Diabetes Complications
Figure 3: Global: Breakup of Diabetes Patients by Region, (in %) 2024 & 2033
Figure 4: Body Mass Index and Relative risk of Type-2 Diabetes
Figure 5: UK: Total Number of Diabetes Patients (in 000), 2019-2024
Figure 6: UK: Total Number of Diabetes Patients Forecast (in 000), 2025-2033
Figure 7: UK (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2019-2024
Figure 8: UK (Type1 & Type2): Total Number of Diabetes Patients Forecast (in 000), 2025-2033
Figure 9: UK (Urban & Rural): Total Number of Diabetes Patients (in 000), 2019-2024
Figure 10: UK (Urban & Rural): Total Number of Diabetes Patients Forecast (in 000), 2025-2033
Figure 11: UK (Male & Female): Total Number of Diabetes Patients (in 000), 2019-2024
Figure 12: UK (Male & Female): Total Number of Diabetes Patients Forecast (in 000), 2025-2033
Figure 13: UK: Total Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79, in 000), 2019-2024
Figure 14: UK: Total Number of Diabetes Patients Forecast by Age Group (20-39, 40-59, 60-79, in 000), 2025-2033
Figure 15: UK: Diabetes Drug Industry Overview
Figure 16: UK: Diabetes Drug Market: Sales Value (in Billion USD), 2019-2024
Figure 17: UK: Diabetes Drug Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 18: UK: Diabetes Drug Market: SWOT Analysis
Figure 19: UK: Diabetes Drug Market: Value Chain Analysis
Figure 20: UK: Diabetes Drug Market: Porters Five Forces Analysis
Figure 21: UK: Diabetes Drug Market: Breakup of Insulin and Oral Antidiabetics (in %), 2019-2024
Figure 22: UK: Diabetes Drug Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2025-2033
Figure 23: UK: Oral Antidiabetics Market: Sales Value (in Million USD), 2019-2024
Figure 24: UK: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2019 & 2024
Figure 25: UK: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
Figure 26: UK: Oral Antidiabetics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: UK: Insulin Market: Sales Value (in Million USD), 2019-2024
Figure 28: UK: Breakup of Insulin Market by Class (in %), 2019 & 2024
Figure 29: UK: Insulin Market: Sales Share of Key Players (in %)
Figure 30: UK: Insulin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: UK: Diabetes Drug Market: Breakup by Distribution Channel (in %), 2020-2025
Figure 32: UK: Diabetes Drug Market Forecast: Breakup by Distribution Channel (in %), 2026-2034
Figure 33: UK: E-commerce and Tele-pharmacy: Sales Value (in Million USD), 2020-2025
Figure 34: UK: E-commerce and Tele-pharmacy Forecast: Sales Value (in Million USD), 2026-2034
Figure 35: UK: Hospital Pharmacies: Sales Value (in Million USD), 2020-2025
Figure 36: UK: Hospital Pharmacies Forecast: Sales Value (in Million USD), 2026-2034
Figure 37: UK: Retail Pharmacies: Sales Value (in Million USD), 2020-2025
Figure 38: UK: Retail Pharmacies Forecast: Sales Value (in Million USD), 2026-2034
Figure 1: The Impact of Diabetes in the Human Body
Figure 2: Diabetes Complications
Figure 3: Global: Breakup of Diabetes Patients by Region, (in %) 2024 & 2033
Figure 4: Body Mass Index and Relative risk of Type-2 Diabetes
Figure 5: UK: Total Number of Diabetes Patients (in 000), 2019-2024
Figure 6: UK: Total Number of Diabetes Patients Forecast (in 000), 2025-2033
Figure 7: UK (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2019-2024
Figure 8: UK (Type1 & Type2): Total Number of Diabetes Patients Forecast (in 000), 2025-2033
Figure 9: UK (Urban & Rural): Total Number of Diabetes Patients (in 000), 2019-2024
Figure 10: UK (Urban & Rural): Total Number of Diabetes Patients Forecast (in 000), 2025-2033
Figure 11: UK (Male & Female): Total Number of Diabetes Patients (in 000), 2019-2024
Figure 12: UK (Male & Female): Total Number of Diabetes Patients Forecast (in 000), 2025-2033
Figure 13: UK: Total Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79, in 000), 2019-2024
Figure 14: UK: Total Number of Diabetes Patients Forecast by Age Group (20-39, 40-59, 60-79, in 000), 2025-2033
Figure 15: UK: Diabetes Drug Industry Overview
Figure 16: UK: Diabetes Drug Market: Sales Value (in Billion USD), 2019-2024
Figure 17: UK: Diabetes Drug Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 18: UK: Diabetes Drug Market: SWOT Analysis
Figure 19: UK: Diabetes Drug Market: Value Chain Analysis
Figure 20: UK: Diabetes Drug Market: Porters Five Forces Analysis
Figure 21: UK: Diabetes Drug Market: Breakup of Insulin and Oral Antidiabetics (in %), 2019-2024
Figure 22: UK: Diabetes Drug Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2025-2033
Figure 23: UK: Oral Antidiabetics Market: Sales Value (in Million USD), 2019-2024
Figure 24: UK: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2019 & 2024
Figure 25: UK: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
Figure 26: UK: Oral Antidiabetics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: UK: Insulin Market: Sales Value (in Million USD), 2019-2024
Figure 28: UK: Breakup of Insulin Market by Class (in %), 2019 & 2024
Figure 29: UK: Insulin Market: Sales Share of Key Players (in %)
Figure 30: UK: Insulin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: UK: Diabetes Drug Market: Breakup by Distribution Channel (in %), 2020-2025
Figure 32: UK: Diabetes Drug Market Forecast: Breakup by Distribution Channel (in %), 2026-2034
Figure 33: UK: E-commerce and Tele-pharmacy: Sales Value (in Million USD), 2020-2025
Figure 34: UK: E-commerce and Tele-pharmacy Forecast: Sales Value (in Million USD), 2026-2034
Figure 35: UK: Hospital Pharmacies: Sales Value (in Million USD), 2020-2025
Figure 36: UK: Hospital Pharmacies Forecast: Sales Value (in Million USD), 2026-2034
Figure 37: UK: Retail Pharmacies: Sales Value (in Million USD), 2020-2025
Figure 38: UK: Retail Pharmacies Forecast: Sales Value (in Million USD), 2026-2034
